Nonrecurring Expenses Fund
Schedules
TAFS: 075-0125 /X - Nonrecurring Expenses Fund
| Line # | Split | Description | Amount | Footnotes |
|---|---|---|---|---|
| 1000 | DA1 | Discretionary Actual - Unob Bal:Brought Forward from 75-75-X-0125.005 (CMS), October 1 | $3,244,688 | |
| 1000 | DA2 | Discretionary Actual - Unob Bal:Brought Forward from 75-75-X-0125.006 (FDA), October 1 | $75,210 | |
| 1000 | DA3 | Discretionary Actual - Unob Bal:Brought Forward from 75-75-X-0125.008 (NIH), October 1 | $4,088,284 | |
| 1000 | DA4 | Discretionary Actual - Unob Bal:Brought Forward from 75-75-X-0125.009 (CDC), October 1 | $5,354,101 | |
| 1000 | DA5 | Discretionary Actual - Unob Bal:Brought Forward from 75-X-0125, October 1 | $444,880,204 | |
| 1920 | Total budgetary resources avail (disc. and mand.) | $457,642,487 | ||
| 6018 | Nonrecurring Expenses Fund Projects | $25,713,539 | ||
| 6170 | Apportioned in FY 2027and future fiscal years - Nonrecurring Expenses Fund Projects | $431,928,948 | ||
| 6190 | Total budgetary resources available | $457,642,487 |
Footnotes
Footnotes provide further information about, or establish further legal requirements related to the use of, the funds in a given line or set of lines in an apportionment. If footnotes appear on lines 1920 or 6190, they apply to all the lines in the 1xxx and 6xxx sections, respectively. The following are all the footnotes associated with this file.
No footnotes available.
Notes about this page
- † Links to public laws are automatically generated and are not guaranteed to be accurate.